Rapid response of severe refractory metastatic Crohn's disease to infliximab

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 8, 2001, Pages 940-942

  Miller, Ashley M ^a   Elliott, Peter R ^a   Fink, Roy ^a   Connell, William ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Antitumor necrosis antibody; Crohn's disease; Infliximab; Metastatic

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; CIPROFLOXACIN; CLOTRIMAZOLE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METRONIDAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DEBRIDEMENT; DISEASE COURSE; DRUG EFFECT; ERYTHEMA; FEMALE; HUMAN; METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; WELLBEING;

EID: 0034828652     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02439.x     Document Type: Article

References (13)

1. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: A selective review
2. Metastatic Crohn's disease of the umbilicus
3. Metastatic Crohn's disease. Case report and review of the literature
4. Metastatic cutaneous Crohn's disease
5. Metastatic Crohn's disease of the face
6. Metastatic Crohn's disease
7. Extraintestinal manifestations
8. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
9. Infliximab for the treatment of fistulas in patients with Crohn's disease
10. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen
11. Mycophenolate mofetil in autoimmune and inflammatory skin disorders
12. Surgical management of perineal and metastatic cutaneous Crohn's disease
13. Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2. Report of two cases